ReviewNeuroendocrinology2013

Signaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and Notch.

Yvette Carter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.